Literature DB >> 32544310

Further understanding the connection between Alzheimer's disease and Down syndrome.

Heather M Snyder1, Lisa J Bain2, Adam M Brickman3, Maria C Carrillo1, Anna J Esbensen4, Joaquin M Espinosa5, Fabian Fernandez6, Juan Fortea7,8, Sigan L Hartley9, Elizabeth Head10, James Hendrix11, Priya S Kishnani12, Florence Lai13, Patrick Lao14, Cynthia Lemere15, William Mobley16, Elliott J Mufson17, Huntington Potter18, Shahid H Zaman19, Ann-Charlotte Granholm20,21, H Diana Rosas22, Andre Strydom23, Michelle Sie Whitten24, Michael S Rafii25.   

Abstract

Improved medical care of individuals with Down syndrome (DS) has led to an increase in life expectancy to over the age of 60 years. In conjunction, there has been an increase in age-related co-occurring conditions including Alzheimer's disease (AD). Understanding the factors that underlie symptom and age of clinical presentation of dementia in people with DS may provide insights into the mechanisms of sporadic and DS-associated AD (DS-AD). In March 2019, the Alzheimer's Association, Global Down Syndrome Foundation and the LuMind IDSC Foundation partnered to convene a workshop to explore the state of the research on the intersection of AD and DS research; to identify research gaps and unmet needs; and to consider how best to advance the field. This article provides a summary of discussions, including noting areas of emerging science and discovery, considerations for future studies, and identifying open gaps in our understanding for future focus.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; Down syndrome; trisomy; vascular contributions

Mesh:

Substances:

Year:  2020        PMID: 32544310      PMCID: PMC8865308          DOI: 10.1002/alz.12112

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   16.655


  123 in total

1.  Dementia diagnostic criteria in Down syndrome.

Authors:  Rory Sheehan; Amanda Sinai; Nick Bass; Pippa Blatchford; Ingrid Bohnen; Simon Bonell; Ken Courtenay; Angela Hassiotis; Therese Markar; Jane McCarthy; Kamalika Mukherji; Asim Naeem; Dimitrios Paschos; Natalia Perez-Achiaga; Vijaya Sharma; David Thomas; Zuzana Walker; Andre Strydom
Journal:  Int J Geriatr Psychiatry       Date:  2014-11-03       Impact factor: 3.485

2.  APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy.

Authors:  Kristel Sleegers; Nathalie Brouwers; Ilse Gijselinck; Jessie Theuns; Dirk Goossens; Jan Wauters; Jurgen Del-Favero; Marc Cruts; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Brain       Date:  2006-08-18       Impact factor: 13.501

Review 3.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

4.  Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.

Authors:  Oliver Preische; Stephanie A Schultz; Anja Apel; Jens Kuhle; Stephan A Kaeser; Christian Barro; Susanne Gräber; Elke Kuder-Buletta; Christian LaFougere; Christoph Laske; Jonathan Vöglein; Johannes Levin; Colin L Masters; Ralph Martins; Peter R Schofield; Martin N Rossor; Neill R Graff-Radford; Stephen Salloway; Bernardino Ghetti; John M Ringman; James M Noble; Jasmeer Chhatwal; Alison M Goate; Tammie L S Benzinger; John C Morris; Randall J Bateman; Guoqiao Wang; Anne M Fagan; Eric M McDade; Brian A Gordon; Mathias Jucker
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

5.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease.

Authors:  Randall J Bateman; Paul S Aisen; Bart De Strooper; Nick C Fox; Cynthia A Lemere; John M Ringman; Stephen Salloway; Reisa A Sperling; Manfred Windisch; Chengjie Xiong
Journal:  Alzheimers Res Ther       Date:  2011-01-06       Impact factor: 6.982

6.  Sleep in Alzheimer's Disease - Beyond Amyloid.

Authors:  Jerrah Holth; Tirth Patel; David M Holtzman
Journal:  Neurobiol Sleep Circadian Rhythms       Date:  2016-08-10

7.  Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease.

Authors:  Piotr Lewczuk; Natalia Ermann; Ulf Andreasson; Christian Schultheis; Jana Podhorna; Philipp Spitzer; Juan Manuel Maler; Johannes Kornhuber; Kaj Blennow; Henrik Zetterberg
Journal:  Alzheimers Res Ther       Date:  2018-07-28       Impact factor: 6.982

8.  The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort.

Authors:  Alison K Godbolt; Lisa Cipolotti; Hilary Watt; Nick C Fox; John C Janssen; Martin N Rossor
Journal:  Arch Neurol       Date:  2004-11

Review 9.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

10.  Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.

Authors:  Brian A Gordon; Tyler M Blazey; Yi Su; Amrita Hari-Raj; Aylin Dincer; Shaney Flores; Jon Christensen; Eric McDade; Guoqiao Wang; Chengjie Xiong; Nigel J Cairns; Jason Hassenstab; Daniel S Marcus; Anne M Fagan; Clifford R Jack; Russ C Hornbeck; Katrina L Paumier; Beau M Ances; Sarah B Berman; Adam M Brickman; David M Cash; Jasmeer P Chhatwal; Stephen Correia; Stefan Förster; Nick C Fox; Neill R Graff-Radford; Christian la Fougère; Johannes Levin; Colin L Masters; Martin N Rossor; Stephen Salloway; Andrew J Saykin; Peter R Schofield; Paul M Thompson; Michael M Weiner; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Lancet Neurol       Date:  2018-02-01       Impact factor: 44.182

View more
  18 in total

1.  The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Authors:  Md Mahiuddin Ahmed; Athena Ching-Jung Wang; Mihret Elos; Heidi J Chial; Stefan Sillau; D Adriana Solano; Christina Coughlan; Leila Aghili; Paige Anton; Neil Markham; Vanesa Adame; Katheleen J Gardiner; Timothy D Boyd; Huntington Potter
Journal:  Neurobiol Dis       Date:  2022-03-18       Impact factor: 7.046

2.  Factors associated with the reporting of Down syndrome as the underlying cause of death on US death certificates.

Authors:  S D Landes; M A Turk; J M Finan
Journal:  J Intellect Disabil Res       Date:  2022-02-21

3.  Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.

Authors:  Mariko Sawa; Cassia Overk; Ann Becker; Dominique Derse; Ricardo Albay; Kim Weldy; Ahmad Salehi; Thomas G Beach; Eric Doran; Elizabeth Head; Y Eugene Yu; William C Mobley
Journal:  Alzheimers Dement       Date:  2021-11-10       Impact factor: 16.655

Review 4.  Cell models for Down syndrome-Alzheimer's disease research.

Authors:  Yixing Wu; Nicole R West; Anita Bhattacharyya; Frances K Wiseman
Journal:  Neuronal Signal       Date:  2022-04-08

Review 5.  Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer's Disease.

Authors:  Jose L Martinez; Matthew D Zammit; Nicole R West; Bradley T Christian; Anita Bhattacharyya
Journal:  Front Aging Neurosci       Date:  2021-07-12       Impact factor: 5.702

6.  Developmental deficits and staging of dynamics of age associated Alzheimer's disease neurodegeneration and neuronal loss in subjects with Down syndrome.

Authors:  Jerzy Wegiel; Michael Flory; Izabela Kuchna; Krzysztof Nowicki; Jarek Wegiel; Shuang Yong Ma; Nanbert Zhong; Teresa Wierzba Bobrowicz; Mony de Leon; Florence Lai; Wayne P Silverman; Thomas Wisniewski
Journal:  Acta Neuropathol Commun       Date:  2022-01-04       Impact factor: 7.801

7.  Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer's disease pathology in Down syndrome.

Authors:  Alison M Maxwell; Peng Yuan; Brianna M Rivera; Wilder Schaaf; Mihovil Mladinov; Vee P Prasher; Andrew C Robinson; William F DeGrado; Carlo Condello
Journal:  Acta Neuropathol Commun       Date:  2021-12-27       Impact factor: 7.578

8.  AKT Hyperphosphorylation and T Cell Exhaustion in Down Syndrome.

Authors:  Daphne Peeters; Ingrid Pico-Knijnenburg; Douwe Wieringa; Mandana Rad; Roos Cuperus; Madelon Ruige; Frank Froeling; Gerda W Zijp; Mirjam van der Burg; Gertjan J A Driessen
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

9.  Chromosome Instability, Aging and Brain Diseases.

Authors:  Ivan Y Iourov; Yuri B Yurov; Svetlana G Vorsanova; Sergei I Kutsev
Journal:  Cells       Date:  2021-05-19       Impact factor: 6.600

10.  The Janus-like Association between Proton Pump Inhibitors and Dementia.

Authors:  Anna Papazoglou; Muhammad I Arshaad; Christina Henseler; Johanna Daubner; Karl Broich; Britta Haenisch; Marco Weiergräber
Journal:  Curr Alzheimer Res       Date:  2021       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.